Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Role of Erythropoietin in Cerebral Glioma: An Innovative Target in Neuro-Oncology.

Torregrossa F, Aguennouz M, La Torre D, Sfacteria A, Grasso G.

World Neurosurg. 2019 Nov;131:346-355. doi: 10.1016/j.wneu.2019.06.221.

PMID:
31658577
2.

Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination.

Efthymiou S, Salpietro V, Malintan N, Poncelet M, Kriouile Y, Fortuna S, De Zorzi R, Payne K, Henderson LB, Cortese A, Maddirevula S, Alhashmi N, Wiethoff S, Ryten M, Botia JA, Provitera V, Schuelke M, Vandrovcova J; SYNAPS Study Group , Walsh L, Torti E, Iodice V, Najafi M, Karimiani EG, Maroofian R, Siquier-Pernet K, Boddaert N, De Lonlay P, Cantagrel V, Aguennouz M, El Khorassani M, Schmidts M, Alkuraya FS, Edvardson S, Nolano M, Devaux J, Houlden H.

Brain. 2019 Oct 1;142(10):2948-2964. doi: 10.1093/brain/awz248.

3.

Hippo signaling pathway is altered in Duchenne muscular dystrophy.

Vita GL, Polito F, Oteri R, Arrigo R, Ciranni AM, Musumeci O, Messina S, Rodolico C, Di Giorgio RM, Vita G, Aguennouz M.

PLoS One. 2018 Oct 10;13(10):e0205514. doi: 10.1371/journal.pone.0205514. eCollection 2018.

4.

Autoimmunität gegen heterogenes nukleäres Ribonukleoprotein A1 bei Psoriasispatienten und Korrelation mit dem Schweregrad der Erkrankung.

Guarneri C, Aguennouz M, Guarneri F, Polito F, Benvenga S, Cannavò SP.

J Dtsch Dermatol Ges. 2018 Sep;16(9):1103-1108. doi: 10.1111/ddg.13631_g.

PMID:
30179340
5.

Autoimmunity to heterogeneous nuclear ribonucleoprotein A1 in psoriatic patients and correlation with disease severity.

Guarneri C, Aguennouz M, Guarneri F, Polito F, Benvenga S, Cannavò SP.

J Dtsch Dermatol Ges. 2018 Sep;16(9):1103-1107. doi: 10.1111/ddg.13631.

PMID:
30179318
6.

Silencing of telomere-binding protein adrenocortical dysplasia (ACD) homolog enhances radiosensitivity in glioblastoma cells.

Polito F, Cucinotta M, Abbritti RV, Brogna A, Pergolizzi S, Tomasello C, Barresi V, Angileri FF, Di Giorgio R, Conti A, La Torre D, Germanò A, Aguennouz M.

Transl Res. 2018 Dec;202:99-108. doi: 10.1016/j.trsl.2018.07.005. Epub 2018 Jul 20.

PMID:
30080989
7.

miRNA expression profiling regulates necroptotic cell death in hepatocellular carcinoma.

Visalli M, Bartolotta M, Polito F, Oteri R, Barbera A, Arrigo R, Di Giorgio RM, Navarra G, Aguennouz M.

Int J Oncol. 2018 Aug;53(2):771-780. doi: 10.3892/ijo.2018.4410. Epub 2018 May 17.

PMID:
29845207
8.

miRNA regulation of Sirtuin-1 expression in human astrocytoma.

Romeo SG, Conti A, Polito F, Tomasello C, Barresi V, La Torre D, Cucinotta M, Angileri FF, Bartolotta M, Di Giorgio RM, Aguennouz M.

Oncol Lett. 2016 Oct;12(4):2992-2998. Epub 2016 Aug 5.

9.

Meningiomas and Proteomics: Focus on New Potential Biomarkers and Molecular Pathways.

Abbritti RV, Polito F, Cucinotta M, Lo Giudice C, Caffo M, Tomasello C, Germanò A, Aguennouz M.

Cancer Genomics Proteomics. 2016 09-10;13(5):369-79. Review.

10.

MicroRNA signatures predict dysregulated vitamin D receptor and calcium pathways status in limb girdle muscle dystrophies (LGMD) 2A/2B.

Aguennouz M, Lo Giudice C, Licata N, Rodolico C, Musumeci O, Fanin M, Migliorato A, Ragusa M, Macaione V, Di Giorgio RM, Angelini C, Toscano A.

Cell Biochem Funct. 2016 Aug;34(6):414-22. doi: 10.1002/cbf.3202.

PMID:
27558075
11.

MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.

Conti A, Romeo SG, Cama A, La Torre D, Barresi V, Pezzino G, Tomasello C, Cardali S, Angileri FF, Polito F, Ferlazzo G, Di Giorgio R, Germanò A, Aguennouz M.

Tumour Biol. 2016 Oct;37(10):14035-14048. Epub 2016 Aug 6.

PMID:
27495233
12.

Analysis of lipid profile in lipid storage myopathy.

Aguennouz M, Beccaria M, Purcaro G, Oteri M, Micalizzi G, Musumesci O, Ciranni A, Di Giorgio RM, Toscano A, Dugo P, Mondello L.

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Sep 1;1029-1030:157-168. doi: 10.1016/j.jchromb.2016.06.039. Epub 2016 Jul 1.

PMID:
27428459
13.

Prognostic value of HMGB1 and oxidative stress markers in multiple trauma patients: A single-centre prospective study.

Polito F, Cicciu' M, Aguennouz M, Cucinotta M, Cristani M, Lauritano F, Sindoni A, Gioffre'-Florio M, Fama F.

Int J Immunopathol Pharmacol. 2016 Sep;29(3):504-9. doi: 10.1177/0394632016656187. Epub 2016 Jun 24.

14.

Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice.

Messina S, Bitto A, Vita GL, Aguennouz M, Irrera N, Licata N, Sframeli M, Bruschetta D, Minutoli L, Altavilla D, Vita G, Squadrito F.

Biofactors. 2015 Sep-Oct;41(5):324-9. doi: 10.1002/biof.1226. Epub 2015 Aug 31.

PMID:
26332024
15.

Recurrent rhabdomyolysis due to muscle β-enolase deficiency: very rare or underestimated?

Musumeci O, Brady S, Rodolico C, Ciranni A, Montagnese F, Aguennouz M, Kirk R, Allen E, Godfrey R, Romeo S, Murphy E, Rahman S, Quinlivan R, Toscano A.

J Neurol. 2014 Dec;261(12):2424-8. doi: 10.1007/s00415-014-7512-7. Epub 2014 Sep 30.

PMID:
25267339
16.

Matrix metalloproteinase 9 and transglutaminase 2 expression at the ocular surface in patients with different forms of dry eye disease.

Aragona P, Aguennouz M, Rania L, Postorino E, Sommario MS, Roszkowska AM, De Pasquale MG, Pisani A, Puzzolo D.

Ophthalmology. 2015 Jan;122(1):62-71. doi: 10.1016/j.ophtha.2014.07.048. Epub 2014 Sep 18.

PMID:
25240629
17.

Telomere instability in papillary bladder urothelial carcinomas: Comparison with grading and risk of recurrence.

Mucciardi G, Gali' A, Barresi V, Mucciardi M, Aguennouz M, Inferrera A, Magno C.

Indian J Urol. 2014 Jul;30(3):245-51. doi: 10.4103/0970-1591.134241.

18.

Telomere length modulation in human astroglial brain tumors.

La Torre D, Conti A, Aguennouz MH, De Pasquale MG, Romeo S, Angileri FF, Cardali S, Tomasello C, Alafaci C, Germanò A.

PLoS One. 2013 May 14;8(5):e64296. doi: 10.1371/journal.pone.0064296. Print 2013.

19.

ANT1 is reduced in sporadic inclusion body myositis.

Barca E, Aguennouz M, Mazzeo A, Messina S, Toscano A, Vita GL, Portaro S, Parisi D, Rodolico C.

Neurol Sci. 2013 Feb;34(2):217-24. doi: 10.1007/s10072-012-0976-2. Epub 2012 Feb 21.

PMID:
22350218
20.

Relationship between advanced oxidation protein products, advanced glycation end products, and S-nitrosylated proteins with biological risk and MDR-1 polymorphisms in patients affected by B-chronic lymphocytic leukemia.

Gangemi S, Allegra A, Aguennouz M, Alonci A, Speciale A, Cannavò A, Cristani M, Russo S, Spatari G, Alibrandi A, Musolino C.

Cancer Invest. 2012 Jan;30(1):20-6. doi: 10.3109/07357907.2011.629383.

PMID:
22236186
21.

Clinical features and new molecular findings in muscle phosphofructokinase deficiency (GSD type VII).

Musumeci O, Bruno C, Mongini T, Rodolico C, Aguennouz M, Barca E, Amati A, Cassandrini D, Serlenga L, Vita G, Toscano A.

Neuromuscul Disord. 2012 Apr;22(4):325-30. doi: 10.1016/j.nmd.2011.10.022. Epub 2011 Nov 30.

PMID:
22133655
22.

Involvement of T2677T multidrug resistance gene polymorphism in Interleukin 22 plasma concentration in B-chronic lymphocytic leukemia patients.

Musolino C, Allegra A, Ferraro M, Aguennouz M, Russo S, Alonci A, Saitta S, Gangemi S.

Acta Oncol. 2012 Mar;51(3):406-8. doi: 10.3109/0284186X.2011.631577. Epub 2011 Nov 9. No abstract available.

PMID:
22070651
23.

Potential clinical role of telomere length in human glioblastoma.

La Torre D, Aguennouz M, Conti A, Giusa M, Raffa G, Abbritti RV, Germano' A, Angileri FF.

Transl Med UniSa. 2011 Oct 17;1:243-70. Print 2011 Sep.

24.

Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age.

Messina S, Vita GL, Aguennouz M, Sframeli M, Romeo S, Rodolico C, Vita G.

Acta Myol. 2011 Jun;30(1):16-23.

25.

The soy isoflavone genistein blunts nuclear factor kappa-B, MAPKs and TNF-α activation and ameliorates muscle function and morphology in mdx mice.

Messina S, Bitto A, Aguennouz M, Vita GL, Polito F, Irrera N, Altavilla D, Marini H, Migliorato A, Squadrito F, Vita G.

Neuromuscul Disord. 2011 Aug;21(8):579-89. doi: 10.1016/j.nmd.2011.04.014. Epub 2011 Jun 11.

PMID:
21658942
26.

MDR-1 gene polymorphisms G2677T and C3435T in a case of Hodgkin's variant of Richter's syndrome.

Penna G, Allegra A, Alonci A, Aguennouz M, Cannavò A, Russo S, Granata A, Musolino C.

Oncol Lett. 2011 Mar;2(2):379-381. Epub 2011 Jan 20.

27.

MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis.

Penna G, Allegra A, Alonci A, Aguennouz M, Garufi A, Cannavò A, Gerace D, Alibrandi A, Musolino C.

Med Oncol. 2011 Dec;28(4):1549-54. doi: 10.1007/s12032-010-9561-9. Epub 2010 May 22.

PMID:
20496015
28.

Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy.

Aguennouz M, Vita GL, Messina S, Cama A, Lanzano N, Ciranni A, Rodolico C, Di Giorgio RM, Vita G.

Neurobiol Aging. 2011 Dec;32(12):2190-7. doi: 10.1016/j.neurobiolaging.2010.01.008. Epub 2010 Feb 5.

PMID:
20137830
29.

Role of inflammation and oxidative stress mediators in gliomas.

Conti A, Gulì C, La Torre D, Tomasello C, Angileri FF, Aguennouz M.

Cancers (Basel). 2010 Apr 26;2(2):693-712. doi: 10.3390/cancers2020693.

30.

Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisolone.

Messina S, Bitto A, Aguennouz M, Mazzeo A, Migliorato A, Polito F, Irrera N, Altavilla D, Vita GL, Russo M, Naro A, De Pasquale MG, Rizzuto E, Musarò A, Squadrito F, Vita G.

Exp Neurol. 2009 Dec;220(2):349-58. doi: 10.1016/j.expneurol.2009.09.015. Epub 2009 Sep 25.

PMID:
19786019
31.

miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors.

Conti A, Aguennouz M, La Torre D, Tomasello C, Cardali S, Angileri FF, Maio F, Cama A, Germanò A, Vita G, Tomasello F.

J Neurooncol. 2009 Jul;93(3):325-32. doi: 10.1007/s11060-009-9797-4. Epub 2009 Jan 22.

PMID:
19159078
32.

Regulation of interleukin-8 gene at a distinct site of its promoter by CCAAT enhancer-binding protein homologous protein in prostaglandin E2-treated human T cells.

Cucinotta M, Visalli M, Aguennouz M, Valenti A, Loddo S, Altucci L, Teti D.

J Biol Chem. 2008 Oct 31;283(44):29760-9. doi: 10.1074/jbc.M803145200. Epub 2008 Sep 4.

33.

Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.

Angileri FF, Aguennouz M, Conti A, La Torre D, Cardali S, Crupi R, Tomasello C, Germanò A, Vita G, Tomasello F.

Cancer. 2008 May 15;112(10):2258-66. doi: 10.1002/cncr.23407.

34.

Type I hyperprolinemia and proline dehydrogenase (PRODH) mutations in four Italian children with epilepsy and mental retardation.

Di Rosa G, Pustorino G, Spano M, Campion D, Calabrò M, Aguennouz M, Caccamo D, Legallic S, Sgro DL, Bonsignore M, Tortorella G.

Psychiatr Genet. 2008 Feb;18(1):40-2. doi: 10.1097/YPG.0b013e3282f08a3d.

PMID:
18197084
35.

Novel SHOX gene mutation in a short boy with Becker muscular dystrophy: double trouble in two adjacent genes.

Messina MF, Aguennouz M, Arrigo T, Rodolico C, Valenzise M, Musumeci O, Vita G, Lanzano N, De Luca F.

Horm Res. 2008;69(2):124-8. Epub 2007 Dec 5.

PMID:
18059093
36.

Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies.

Macaione V, Aguennouz M, Mazzeo A, De Pasquale MG, Russo M, Toscano A, De Luca G, Di Giorgio RM, Vita G, Rodolico C.

Acta Neurol Scand. 2008 Jun;117(6):393-8. Epub 2007 Nov 14.

PMID:
18005224
37.

Clinical, molecular, and protein correlations in a large sample of genetically diagnosed Italian limb girdle muscular dystrophy patients.

Guglieri M, Magri F, D'Angelo MG, Prelle A, Morandi L, Rodolico C, Cagliani R, Mora M, Fortunato F, Bordoni A, Del Bo R, Ghezzi S, Pagliarani S, Lucchiari S, Salani S, Zecca C, Lamperti C, Ronchi D, Aguennouz M, Ciscato P, Di Blasi C, Ruggieri A, Moroni I, Turconi A, Toscano A, Moggio M, Bresolin N, Comi GP.

Hum Mutat. 2008 Feb;29(2):258-66.

PMID:
17994539
38.

Clinical features and new molecular findings in Carnitine Palmitoyltransferase II (CPT II) deficiency.

Corti S, Bordoni A, Ronchi D, Musumeci O, Aguennouz M, Toscano A, Lamperti C, Bresolin N, Comi GP.

J Neurol Sci. 2008 Mar 15;266(1-2):97-103. Epub 2007 Oct 23.

PMID:
17936304
39.

Identification of the infant-type R631C mutation in patients with the benign muscular form of CPT2 deficiency.

Musumeci O, Aguennouz M, Comi GP, Rodolico C, Autunno M, Bordoni A, Baratta S, Taroni F, Vita G, Toscano A.

Neuromuscul Disord. 2007 Dec;17(11-12):960-3. Epub 2007 Jul 24.

PMID:
17651973
40.

VEGF overexpression via adeno-associated virus gene transfer promotes skeletal muscle regeneration and enhances muscle function in mdx mice.

Messina S, Mazzeo A, Bitto A, Aguennouz M, Migliorato A, De Pasquale MG, Minutoli L, Altavilla D, Zentilin L, Giacca M, Squadrito F, Vita G.

FASEB J. 2007 Nov;21(13):3737-46. Epub 2007 Jun 15.

PMID:
17575261
41.

RAGE-NF-kappaB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy.

Macaione V, Aguennouz M, Rodolico C, Mazzeo A, Patti A, Cannistraci E, Colantone L, Di Giorgio RM, De Luca G, Vita G.

Acta Neurol Scand. 2007 Feb;115(2):115-21.

PMID:
17212615
42.

Immunohistochemical analysis of human skeletal muscle AMP deaminase deficiency. Evidence of a correlation between the muscle HPRG content and the level of the residual AMP deaminase activity.

Sabbatini AR, Toscano A, Aguennouz M, Martini D, Polizzi E, Ranieri-Raggi M, Moir AJ, Migliorato A, Musumeci O, Vita G, Raggi A.

J Muscle Res Cell Motil. 2006;27(1):83-92. Epub 2006 Mar 29.

PMID:
16570231
43.

Immunolocalization and activation of nuclear factor-kappaB in the sciatic nerves of rats with experimental autoimmune neuritis.

Laurà M, Mazzeo A, Aguennouz M, Santoro M, Catania MA, Migliorato A, Calapai G, Vita G.

J Neuroimmunol. 2006 May;174(1-2):32-8. Epub 2006 Mar 6.

PMID:
16516982
44.

Lipid peroxidation inhibition blunts nuclear factor-kappaB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice.

Messina S, Altavilla D, Aguennouz M, Seminara P, Minutoli L, Monici MC, Bitto A, Mazzeo A, Marini H, Squadrito F, Vita G.

Am J Pathol. 2006 Mar;168(3):918-26.

45.

New mutations in TK2 gene associated with mitochondrial DNA depletion.

Galbiati S, Bordoni A, Papadimitriou D, Toscano A, Rodolico C, Katsarou E, Sciacco M, Garufi A, Prelle A, Aguennouz M', Bonsignore M, Crimi M, Martinuzzi A, Bresolin N, Papadimitriou A, Comi GP.

Pediatr Neurol. 2006 Mar;34(3):177-85.

PMID:
16504786
46.

Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice.

Messina S, Bitto A, Aguennouz M, Minutoli L, Monici MC, Altavilla D, Squadrito F, Vita G.

Exp Neurol. 2006 Mar;198(1):234-41. Epub 2006 Jan 10.

PMID:
16410003
47.

Nuclear factor-kappab activation is associated with glutamate-evoked tissue transglutaminase up-regulation in primary astrocyte cultures.

Caccamo D, Campisi A, Currò M, Aguennouz M, Li Volti G, Avola R, Ientile R.

J Neurosci Res. 2005 Dec 15;82(6):858-65.

PMID:
16273541
48.

Mutation finding in patients with dysferlin deficiency and role of the dysferlin interacting proteins annexin A1 and A2 in muscular dystrophies.

Cagliani R, Magri F, Toscano A, Merlini L, Fortunato F, Lamperti C, Rodolico C, Prelle A, Sironi M, Aguennouz M, Ciscato P, Uncini A, Moggio M, Bresolin N, Comi GP.

Hum Mutat. 2005 Sep;26(3):283.

PMID:
16100712
49.

Specific matrix metalloproteinase expression in focal myositis: an immunopathological study.

Rodolico C, Mazzeo A, Toscano A, Messina S, Aguennouz M, Gaeta M, Messina C, Vita G.

Acta Neurol Scand. 2005 Sep;112(3):173-7.

PMID:
16097959
50.

Oxidative stress in myotonic dystrophy type 1.

Toscano A, Messina S, Campo GM, Di Leo R, Musumeci O, Rodolico C, Aguennouz M, Annesi G, Messina C, Vita G.

Free Radic Res. 2005 Jul;39(7):771-6.

PMID:
16036357

Supplemental Content

Loading ...
Support Center